Does ALPRAZOLAM Cause Product formulation issue? 33 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Product formulation issue have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.1% of all adverse event reports for ALPRAZOLAM.
33
Reports of Product formulation issue with ALPRAZOLAM
0.1%
of all ALPRAZOLAM reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product formulation issue From ALPRAZOLAM?
Of the 33 reports, 3 (9.1%) required hospitalization.
Is Product formulation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Product formulation issue?
MINOXIDIL (1,369)
LEVOTHYROXINE (740)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174)
OMEPRAZOLE (99)
METHYLPHENIDATE (78)
OXYCODONE (73)
ACETAMINOPHEN\HYDROCODONE (62)
ACETAMINOPHEN\OXYCODONE (61)
ACETAMINOPHEN (59)
BUPROPION (59)
Which ALPRAZOLAM Alternatives Have Lower Product formulation issue Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE